<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>(2S)-1-(4-Amino-2,3,5-trimethylphenoxy)-3-{4-[4-(4-fluorobenzyl) <z:chebi fb="1" ids="30396">phenyl</z:chebi>]-1-piperazinyl}-2-propanol dimethanesulfonate (SUN N8075) is a novel <z:chebi fb="11" ids="22586">antioxidant</z:chebi> with neuroprotective properties </plain></SENT>
<SENT sid="1" pm="."><plain>We examined whether SUN N8075 inhibited the neuronal damage resulting from permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, and examined its neuroprotective properties in vivo and in vitro mechanism </plain></SENT>
<SENT sid="2" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced by permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in mice, and the resulting <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">infarction, brain</z:e> swelling, and neurological deficits were evaluated after 24 h or 72 h </plain></SENT>
<SENT sid="3" pm="."><plain>Brain damage was assessed histochemically using terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end-labeling (TUNEL) staining and antibody recognizing <z:chebi fb="0" ids="32585">4-hydroxynonenal</z:chebi> histidine adduct (4-HNE) </plain></SENT>
<SENT sid="4" pm="."><plain>In the in vitro study, we examined the effects of SUN N8075 on 1) <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation in mouse brain homogenates and 2) cell viability and caspase-3 protease activity under a hypoxic insult or FeSO(4) in rat cultured cerebrocortical neurons </plain></SENT>
<SENT sid="5" pm="."><plain>SUN N8075 administered either 10 min before or at 1 h after the occlusion reduced both infarction size and neurological deficits </plain></SENT>
<SENT sid="6" pm="."><plain>SUN N8075 reduced <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> when administered 10 min before, 1 h, or 3 h after occlusion </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, only pretreatment (administered 10 min before) decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> at 72 h after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>SUN N8075 reduced the number of TUNEL-positive cells and decreased the level of oxidative damage, as assessed by immunopositive staining to 4-HNE </plain></SENT>
<SENT sid="9" pm="."><plain>SUN N8075 inhibited <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, leakage of <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase, caspase-3 activation induced by in vitro <z:mp ids='MP_0005039'>hypoxia</z:mp>, and the neuronal damage induced by in vitro FeSO(4) exposure </plain></SENT>
<SENT sid="10" pm="."><plain>These findings indicate that SUN N8075 has neuroprotective effects against <z:hpo ids='HP_0011009'>acute</z:hpo> ischemic neuronal damage in mice and may prove promising as a therapeutic drug for <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>